LDNscience

@UCSNT6A2Vwm3JzpmQTfeQZBg - 2.1K subscribers

LDNscience® is a public information project of the MedInsight® Research Institute. MedInsight® Research Institute is a U.S./U.K. based non-profit organization established in 2006, that serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases. MedInsight employs a graph-oriented database to drive innovation in the field of drug repurposing. Under the leadership of Moshe Rogosnitzky, a scientist and MedInsight's co-founder, LDNscience brings together research and information on Low Dose Naltrexone (LDN) and its application in the treatment of chronic and serious diseases. We collaborate with LDN researchers to bring current information about clinical trials and research to patients, the general public and professional community.